Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREArtificial intelligence is accelerating opportunities. Realizing the benefits for healthcare requires the right expertise. Together, we can solve the problems of today, and drive the breakthroughs of tomorrow.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREIQVIA enables genomic research via global access to a network of genomic-clinical data, proprietary technologies that enable federated analytics, and therapeutic area & bioinformatics expertise to help you answer your most pressing research questions.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSRon Bruehlman is Executive Vice President and Chief Financial Officer of IQVIA. He is responsible for the controllers, FP&A, treasury, tax, internal audit, corporate development, and corporate strategy functions. He assumed this position after serving from October 2016 through July 2020 as Senior Advisor to the CEO of IQVIA, playing an active role in the integration of IMS Health and Quintiles. Prior to that, Ron was Chief Financial Officer of IMS Health from July 2011 through September 2016. He joined IMS Health following the 2010 leveraged buyout led by TPG Capital and subsequently guided the company through its 2014 IPO and its merger of equals with Quintiles in October 2016.
Before joining IMS Health, Ron had a 23-year career at United Technologies Corporation (UTC), where he held multiple senior finance leadership roles of increasing responsibility. These included running UTC’s global corporate development and strategy group, serving as Chief Financial Officer of Carrier Corporation, leading the corporate financial planning and analysis function for UTC, running financial analysis and planning for Otis Elevator, and leading UTC’s investor relations function.
Ron currently serves as a board member and Audit Committee Chair for Atotech Ltd., an NYSE-listed global market leader in plating technologies. Ron previously chaired the board of Q2 Solutions, a joint venture between IQVIA and Quest Diagnostics.
Ron earned a B.S. in economics from the University of Delaware, as well as an MBA in finance from the University of Chicago, Booth School of Business.